We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Noninvasive Device Computes Blood Glucose Levels

By LabMedica International staff writers
Posted on 13 Sep 2010
Raman spectroscopy has been used to measure the amount of glucose in the tissue under the skin without the need to perform phlebotomy. More...


Raman spectroscopy is a technique used to study vibrational, rotational, and other low-frequency modes in a system. It relies on inelastic scattering of monochromatic light, usually from a laser in the visible, near infrared, or near ultraviolet range.

Patients undergoing the oral glucose tolerance test (OGTT) need to have their blood drawn at frequent intervals so that after ingestion of a glucose-rich solution, the level of glucose in the blood can be estimated. This test will determine how quickly glucose is cleared from the blood, an indicator of diabetes, insulin resistance, or reactive hypoglycemia. In a study of 10 healthy volunteers undergoing OGTT, at the Massachusetts Institute of Technology's (MIT) Spectroscopy Laboratory (Cambridge, MA, USA), blood concentrations of glucose were measured every 10 minutes using a clinical glucose analyzer (HemoCue, Inc., Lake Forest, CA, USA).

Raman spectra were collected every five minutes from the forearms of healthy Caucasian and Asian human volunteers undergoing the OGTT. For the excitation source, an 830 nm diode laser was used at an average power of 300 mW on a 1 mm2 skin spot. An f/1.8 spectrograph was coupled to a liquid nitrogen-cooled charge-coupled device for spectral dispersion and acquisition, respectively. A dynamic concentration correction (DCC) calibration method was applied to the Raman spectra results for correlation with the blood glucose results.

The Raman technique actually measures the glucose concentration in the interstitial fluid and not the blood. However, this calibration becomes more difficult immediately after the patient drinks the glucose solution because blood glucose soars rapidly, while it takes 5-10 minutes to see a corresponding surge in the interstitial fluid glucose levels. Therefore, interstitial fluid measurements do not give an accurate picture of what is happening in the bloodstream. To compare the two sets of results, the scientists used an algorithm that relates the two concentrations, allowing them to predict blood glucose levels from the glucose concentration in interstitial fluid. After the algorithm was applied, the results from the two sets of data were very similar.

The scientists reported that using DCC-calibrated Raman spectroscopy significantly boost the accuracy of blood glucose measurements with an average improvement of 15%, and up to 30% in some subjects. The study was published in the June 2010 issue of Analytical Chemistry.

Related Links:
Massachusetts Institute of Technology
HemoCue, Inc.



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.